Skip to main content
Advertisement
Advertisement

APMD

APMD logo

Apnimed, Inc. Common Stock

24.72
USD
Sponsored
-1.50
-5.71%
Sep 22, 11:45 UTC -4
Open

APMD Earnings Reports

Positive Surprise Ratio

APMD beat 1 of 1 last estimates.

100%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Apnimed, Inc. Common Stock earnings per share and revenue

On Sep 08, 2026, APMD reported earnings of -0.34 USD per share (EPS) for Q2 26, beating the estimate of -0.52 USD, resulting in a 34.64% surprise. Revenue reached 12.08 million, compared to an expected --, with a 0.00% difference. The market reacted with a -2.47% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Apnimed, Inc. Common Stock reported EPS of -$0.34, beating estimates by 34.64%, and revenue of $12.08M, 0% as expectations.
The stock price moved down -2.47%, changed from $28.79 before the earnings release to $28.08 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Apnimed, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement